Corticosteroid injections shoulder impingement

Both the group treated with the corticosteroid and the group treated with Hylan G-F 20 demonstrated improvements from baseline WOMAC scores (a median decrease from 55 to 40 points and from 54 to 44 points, respectively; p < for both). The scores according to the Knee Society system did not significantly improve for the patients who received the corticosteroid (median, 58 to 70 points; p = ) or for those who received Hylan G-F 20 (median, 58 to 68 points; p = ). The scores on the visual analog scale improved for patients receiving Hylan G-F 20 (median, 70 to 52 mm; p < ) but not for the patients who received the corticosteroid (median, 64 to 52 mm; p = ). However, no significant differences between the two treatment groups were found with respect to the WOMAC, Knee Society system, or visual analog scale results. Women demonstrated a significant improvement in only one of the six possible outcome-treatment combinations (the WOMAC scale), whereas men demonstrated significant improvements in five of the six outcomes (all measures except the Knee Society rating system).

Corticosteroid injections shoulder impingement

corticosteroid injections shoulder impingement

Media:

corticosteroid injections shoulder impingementcorticosteroid injections shoulder impingementcorticosteroid injections shoulder impingementcorticosteroid injections shoulder impingementcorticosteroid injections shoulder impingement